Letrozole/Ribociclib Succinate | m-entrepreneurship.com

Product Name :
Letrozole/Ribociclib Succinate

Search keywords :
Ribociclib

drugId :
null

Target Vo:
Aromatase

Target Vo Short Name :
Aromatase

Moa_Name:
Aromatase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ALIX Antibody
STAT3 Antibody (YA056)
FOXO3A Antibody: FOXO3A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to FOXO3A. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts